Press Releases

Bethesda, Md., / Brussels, Belgium – The Parenteral Drug Association (PDA) and the International Pharmaceutical Excipients Council Federation (IPEC) as an outcome of its collaboration established in March 2018, today announce the joint publication of a Technical Report for Formalized Risk Assessment for Excipients.

Berlin – The Parenteral Drug Association (PDA) Europe today announced its 2020 events calendar, which includes nine conferences throughout the EU. These events are developed by all-volunteer subject-matter experts who work with PDA staff to help educate pharmaceutical professionals on important topics related to biopharmaceuticals, manufacturing science, and regulatory affairs.

Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the results of its Board of Directors Election for the term beginning January 1, 2020. Each year, PDA’s global membership votes to select new directors for the nonprofit Association’s all volunteer Board of Directors, and the Board appoints one Director. In odd years, the membership elects new volunteer officers, who serve two-year terms (except for the chair elect, who serves for six years as chair-elect, chair, and, finally, as immediate-past-chair).

Bethesda, Md. – The Parenteral Drug Association (PDA) is proud to announce that its “ICH Q7 GMP for APIs” online training module is now endorsed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use as an “ICH Recognised Training Programme.”

Bethesda, Md., – The Parenteral Drug Association (PDA) today announced the participation of U.S. FDA Center for Drug Evaluation and Research Director (CDER), Janet Woodcock, MD, and Johns Hopkins University researcher and author, Thomas Stanton, MA/JD, as keynote speakers for the 2019 PDA Risk Management in the Regulatory Landscape Conference, at the Capital Hilton, Washington, DC, Dec. 9–10. The conference is the first of three during PDA’s first “Quality Week.”

Bethesda, Md. – The Parenteral Drug Association (PDA) announced FujiFilm Kyowa Kirin Biologics, Co., Ltd. has won PDA’s new Drug Delivery Innovation Award and Congruence Medical Solutions and Santen Pharmaceuticals have won PDA’s Partnership in Drug Delivery Innovation Award. The Drug Delivery Awards were introduced in 2019 to recognize technical innovation advancing the field of bio/pharmaceutical manufacturing.

Bethesda, Md. – The Parenteral Drug Association (PDA) and the International Society for Pharmaceutical Engineering (ISPE) today announce the joint publication of a guide for Root Cause Analysis (RCA) to help the pharmaceutical industry improve quality culture by providing recommendations for tools, techniques, and processes.

Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of BSR/PDA Standard 01-201x, Enhancing Purchasing Controls to Support the Biopharmaceutical, Pharmaceutical, Medical Devices and Combination Products Industry for public comment.

Bethesda, Md. – PDA is excited to announce the keynote speakers for the upcoming PDA/FDA Joint Regulatory Conference September 16-18 in Washington, D.C. These and other expert speakers will share their insight on how to improve the continued supply of high-quality drugs, biologics, and novel combination products to patients.

The Parenteral Drug Association (PDA) today announced representatives of seven health authorities have been invited to speak at the 2019 PDA Europe Biomanufacturing Conference, 3-4 September 2019 in Munich, Germany.

Bethesda, Md. – PDA today announces the official launch of its third standard project, “Standard Practice for Quality Risk Management of Aseptic Processes” which is being chaired by Hal Baseman, Chief Operating Officer of ValSource, Inc.

Bethesda, Md. – The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting: Global Healthcare of the Present and the Future, June 25-26 in Amsterdam, The Netherlands, the new location of the European Medicines Agency, where industry and regulatory agencies will present their perspectives on the transformation unfolding in the pharmaceutical sector regarding the digitalization and automation of manufacturing processes.

Bethesda, Md. – The Parenteral Drug Association (PDA) is pleased to announce the speaker lineup for the 2019 PDA EU Advanced Therapy Medicinal Products: Cell and Gene Therapy – From Promise to Cure Conference, in Vilnius, Lithuania, June 4-5. Expert speakers representing industry, government and academia will cover the full breadth of scientific and regulatory considerations for successfully launching and manufacturing cell and gene therapies.

Bethesda, Md. – The Parenteral Drug Association (PDA) is once again well-represented on “the Medicine Maker” Power List—a list that celebrates pharmaceutical professionals for efforts to improve the industry in various ways. PDA President & CEO Richard Johnson, past-chairs Hal Baseman, Maik Jornitz and James Agalloco are recognized on the “Industry Influencer” list and past-chair Martin Van Trieste is on the “Champions of Change” list.

Bethesda, Md., – The Parenteral Drug Association (PDA) is proud to present the second annual Pharmacopoeia Conference, at the Crown Plaza Geneva, Switzerland, May 16-17.

Bethesda, Md. – The Parenteral Drug Association (PDA) today confirmed five speakers representing global pharmaceutical regulatory agencies at the 2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges, at the Hilton Long Beach, Long Beach, Calif., May 9 – 10, 2019.

Bethesda, Md. – The Parenteral Drug Association (PDA) today announced that Yonghua Gao, Deputy Secretary General at the China National Pharmaceutical Packaging Association will present a regulatory update of China’s packaging laws at the 2019 PDA Europe Parenteral Packaging Conference, March 19 – 20, at the Hilton Molino Stucky Venice, Italy.

Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the opening of PDA Asia Pacific, the U.S.-based Association’s second overseas office.

Bethesda, Md., – The Parenteral Drug Association (PDA) announced plans to release the results of its 2019 Technology Transfers Survey during the 2019 PDA Annual Meeting at the Marriott Marquis San Diego, Calif., March 11 – 13. The survey results will be discussed at the Technology Transfer Interest Group session on Tue., March 12, 10:45 – 12:15.

Bethesda, Md., – The Parenteral Drug Association (PDA) today announced plans to offer its industry-leading courses in pharmaceutical science and aseptic processing in Bangalore, India to serve the industry at-large there. The first course, Aseptic Techniques, will be held in March 2019 and the final course, Microbial Data Deviations will be held in November.

Bethesda, Md. – The Parenteral Drug Association (PDA) is excited to announce the launch of its new-look website, www.pda.org.